IntelliPharmaCeutics and Vasogen (VSGN) Complete Arrangement to Create Publicly-traded Specialty Pharmaceutical Company
10/22/2009 10:58:01 AM
More...
|
Vasogen (VSGN) and IntelliPharmaCeutics Jointly Announce Shareholder Approval of Plan of Arrangement and Merger
10/20/2009 10:42:15 AM
More...
|
Vasogen (VSGN) Announces Third Quarter 2009 Results
10/15/2009 9:16:23 AM
More...
|
Vasogen (VSGN) Receives NASDAQ Notification Related to Minimum Bid Price
8/17/2009 8:37:16 AM
More...
|
Vasogen (VSGN) and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company; Vasogen Also Raises $7.5 Million
8/17/2009 6:35:29 AM
More...
|
Vasogen (VSGN) Announces Second Quarter 2009 Results
7/15/2009 8:44:24 AM
More...
|
Vasogen (VSGN) Appoints Dr. Eldon Smith Chairman
4/27/2009 12:04:56 PM
More...
|
Vasogen (VSGN) Announces First Quarter 2009 Results
4/14/2009 9:37:39 AM
More...
|
Vasogen (VSGN) Announces Sale of Patent Application and Provides Corporate Update
2/3/2009 11:09:11 AM
More...
|
Vasogen (VSGN) Complies with NASDAQ Marketplace Rule 4350(c)(1)
1/21/2009 8:24:12 AM
More...
|
|